AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Analgesic Effects of Retro-superior Costotransverse Ligament Space Block for Video-assisted Thoracoscopic Surgery

RecruitingNAAges 18 Years - 80 YearsAllNanjing First Hospital, Nanjing Medical University
💬

In plain words

What the trial is, and whether it could suit you

The aim of this clinical trial is to investigate the effects of postoperative analgesia during retro-SCTLB(retro superior costotransverse ligament space block) and TPVB(thoracic paravertebral block) in patients undergoing thoracoscopic radical resection of lung cancer。By comparing the dosage of opioid drugs after surgery, the impact of retro-SCTLB and TPVB on the postoperative analgesic effect was evaluated.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Patients scheduled for thoracoscopic radical lung cancer surgery under general anesthesia; * aged 18-80 years; * BMI 18-30 kg/m²; * ASA classification I-III; Exclusion Criteria: * Allergy to the study drug or local anesthetic; * History of opioid abuse; * Pre-existing skin infection at the puncture site of ITPN or TPVB; * Peripheral infectious neuropathy; * Dysfunction of blood coagulation;
💊

What it tests

  • Ultrasound-guided retro-SCTLB
  • Ultrasound-guided TPVB
📍

Where

1 site
Nanjing First Hospital
Nanjing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy